Skip to main content

Advertisement

Log in

Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates

  • Case Report
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

The aim of the study is to report the rare association of two complications of long-term treatment of osteoporosis with bisphosphonates in the same Caucasian elderly patient. A female patient of Italian descent, age 87 years, consulted in February 2013. She had a history of osteoporosis and had taken alendronate weekly for 7 years (1999–2006). Due to low back pain, an orthopedist had indicated i.v. zoledronic acid, 5 mg/year for 3 years (2006–2008). She received occasional supplements of ergocalciferol. In 2009, she suffered a fall and sustained a subtrochanteric fracture of the left femur. She was operated on and recovered uneventfully. In 2012, she consulted a dentist due to loose teeth. She underwent the removal of a molar and was given a denture. She had discomfort when using the prosthesis, and developed an ulceration in the gum of the mandible, which exposed the bone and did not heal for 2 months. After radiologic studies, the diagnosis was osteonecrosis of the jaw. She improved after surgical debridement and local and systemic antibiotics. In early 2013, laboratory tests were normal except for a slight elevation of serum PTH and CTX-I. Calcitriol 0.25 mcg/day was prescribed; after 3 months serum calcium, phosphate, PTH, and CTX-I showed no variation. Two years later, she experienced acute low back pain after a fall; MRI showed recent crushing of D12, and chronic deformities of D11 and L1. Bone densitometry of her right hip (DXA) showed a T-score of −2.3 at the femoral neck. An X-ray film of the right femur showed diffuse thickening of both cortices. She was treated with nasal calcitonin and analgesics. After the back pain subsided, she was treated with s.c. denosumab. Although the association of ONJ and AFF was known in cancer patients treated with high doses of bisphosphonates, it is very rare in patients with osteoporosis receiving these drugs at usual doses. Only three cases have been reported, all in oriental women. This appears to be the first reported case in a Caucasian woman.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Fleisch H (1987) Bisphosphonates—history and experimental basis. Bone 8(Suppl 1):S23–S28

    PubMed  CAS  Google Scholar 

  2. Adler RA, El-Hajj Fuleihan G, Bauer DC et al (2016) Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res 31:16–35

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Sánchez A (2008) [What are atypical femoral fractures?] (editorial; Spanish). Actual Osteol 8:145–149

    Google Scholar 

  4. Ruggiero SL, Dodson TB, Fantasia J et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg 72:1938–1956

    Article  PubMed  Google Scholar 

  5. Bogdan Y, Tornetta P 3rd, Einhorn TA et al (2016) Healing time and complications in operatively treated atypical femur fractures associated with bisphosphonate use: a multicenter retrospective cohort. J Orthop Trauma 30:177–181

    Article  PubMed  Google Scholar 

  6. Shane E, Burr D, Abrahamsen B et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1–23

    Article  PubMed  Google Scholar 

  7. Kharazmi M, Hallberg P, Michaëlsson K (2014) Gender related difference in the risk of bisphosphonate associated atypical femoral fracture and osteonecrosis of the jaw (letter). Ann Rheum Dis 73:1594

    Article  PubMed  Google Scholar 

  8. Compston J (2011) Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw (review). Osteoporos Int 22:2951–2961

    Article  PubMed  CAS  Google Scholar 

  9. Khan AA, Morrison A, Hanley DA et al (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3–23

    Article  PubMed  Google Scholar 

  10. Chiu WH, Lee JJ, Tsai KS (2013) Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis. J Clin Endocrinol Metab 98:E723–E726

    Article  PubMed  CAS  Google Scholar 

  11. Won Y, Lim JR, Kim YH, Song HK, Yang KH (2014) Atypical femoral fracture combined with osteonecrosis of jaw during osteoporosis treatment with bisphosphonate. J Bone Metab 21:155–160

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kim JE, Yun M, Lim SK, Rhee Y (2015) Concurrent bisphosphonate-related bilateral atypical subtrochanteric fractures and osteonecrosis of the jaw on bone scintigraphy. Clin Nucl Med 40:450–452

    Article  PubMed  Google Scholar 

  13. Grey A, Bolland M, Wattie D, Horne A, Gamble G, Reid IR (2010) Prolonged antiresorptive activity of zoledronate: a randomized, controlled trial. J Bone Miner Res 25:2251–2255

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors express their gratitude to Dr. Guillermo Bruchmann (Sanatorio Británico, Rosario) who gave details about the orthopedic operation of the femur.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Sánchez.

Ethics declarations

Conflicts of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sánchez, A., Blanco, R. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates. Osteoporos Int 28, 1145–1147 (2017). https://doi.org/10.1007/s00198-016-3840-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-016-3840-z

Keywords

Navigation